Mirum
0 followers
MIRM
Performance
About Mirum
Mirum Pharmaceuticals is a biopharmaceutical company focused on developing transformative medicines for rare liver diseases, aiming to create therapies that can significantly improve patients' lives.
Recent News
Mirum Pharmaceuticals to Acquire Bluejay Therapeutics, for Up To $820M
Prediction: Buying This Biotech Stock Today Could Set You Up for Life
Fed Rate Cut Tailwind, Lilly’s Triple Agonist Delivers Big, Vaccine Policy Turmoil — This Week in Biotech #81
Mirum Acquires Bluejay, Adding Brelovitug Treatment for HDV
Mirum Pharma: A Rare Disease Growth Story to Watch
Mirum Pharmaceuticals Reports P-IIb (VISTAS) Trial Data on Volixibat in Primary Sclerosing Cholangitis (PSC) Patients with Cholestatic Pruritus